Media Coverage
ATCC Adds Novel In Vitro Model to Expanding Portfolio
ATCC has released an in vitro model system for a key mechanism of invasion and metastasis in lung cancer as the company continues its efforts to provide drug discovery and development services.
![Outsourcing-Pharma.com logo](https://www.bioagilytix.com/wp-content/uploads/2023/06/Screen-Shot-2018-08-22-at-4.49.29-PM.png)